organizing committee · lectures on the latest scientific discoveries, new trends and problems in...
TRANSCRIPT
Organizing Committee Mijomir Pelemis (Serbia) ChairGoran Stevanovic (Serbia) SecretaryIan Gould (UK) Teresita Mazzei (Italy) Krassimir Metodiev (Bulgaria) Kurt Naber (Germany) Andrea Novelli (Italy) George Petrikkos (Greece) Stefania Stefani (Italy)
Programme and Scientific committee: Kurt Naber (Germany) ChairBojana Beovic (Slovenia) Bruno Barsic (Croatia) Milan Cizman (Slovenia) Ian Gould (UK) Vladimir Krcmery (Slovakia) Teresita Mazzei (Italy) Krassimir Metodiev (Bulgaria) Andrea Novelli (Italy) Milorad Pavlovic (Serbia) George Petrikkos (Greece) Milica Prostran (Serbia) Stefania Stefani (Italy) Milena Svabic Vlahovic (Serbia)
Societies, supporting the conference Association of Infectologists of MontenegroBulgarian Association of Microbiologists Bulgarian Society of ChemotherapyBulgarian Society of Infectious Diseases Bulgarian Society of MicrobiologyCentral European Society of Tropical Medicine Croatian Society of ChemotherapyCroatian Society for Urogenital and Sexually Transmitted InfectionsCyprus Society of Chemotherapy and Infectious Diseases Federation of European Societies for Chemotherapy and Infection (FESCI) Hellenic Society for ChemotherapyInternational Medical Association Bulgaria (IMAB) International Society of Chemotherapy for Infection and Cancer (ISC) Italian Society of ChemotherapyMediterranean Society of ChemotherapyRomanian Society for the Study of Chemotherapeutic Serbian Society of NephrologySociety of Montenegrian Medical DoctorsSlovakian Society of ChemotherapySlovenian Society for Antimicrobial ChemotherapyTurkish Society for Specialists of Infectious Diseases and Clinical Microbiology (EKMUD) Yugoslav Society for Antimicrobial Chemotherapy
Committees
2nd SEEC Chemotherapy and Infection 2011
Belgrade (Beograd) is the capital of Serbia, and has a population of around 1.6 million. It is situated in South-Eastern Europe, on the Balkan Peninsula, at the confluence of the Sava and Danube rivers. It is one of the oldest cities in Europe and has, since ancient times, been a connecting point between the East and West, as well as a land of beautiful scenery and hospitable people. Belgrade is the capital of Serbian culture, education, science and economy. As a result of its tumultuous history, Belgrade has for centuries been home to many nationalities, with Serbs of the Orthodox Christian religion making up the majority of the population (90%). The official language is Serbian, while visitors from abroad can use English to communicate.
Since the establishment of the Yugoslav Society for Antimicrobial Chemotherapy (JUAH), we have made an effort within local and regional boundaries, to provide the latest information and exchange of experiences in different fields of interest, for experts dealing with diagnostic and therapeutic problems in infectious diseases.
The success of the 1st South East European Conference of Chemotherapy and Infection, focusing on regional problems in the field of chemotherapy and infections has provided an opportunity for organise this second meeting. The conference provides a unique opportunity for participants to interact, learn and impart knowledge in the areas of antimicrobial chemotherapy and infectious diseases which play such an important role in the world of medicine around our globe.
The necessity for conferences such as the South East European Conference of Chemotherapy and Infection is obvious, considering the recent developments in microbiology, infectious disease and oncology. We are faced with changes in habitual interactions between humans and microbes, including possible pandemics of respiratory infections and the emergence of new infections. Through the world, including our region, ancient and well-known infectious diseases are re-emerging, and the problem of antimicrobial resistance is still evolving. Also the problem of nosocomial infections and the rising rate of immuno - suppression remain present. As physicians, we are obligated to improve our knowledge and attempt to alter these trends through discussions, exchange of opinions and learning.
The Second South East European Conference of Chemotherapy and Infection will provide a series of expert lectures on the latest scientific discoveries, new trends and problems in public health and recent advances in clinical practice. Therefore, the conference will have an important impact on all medical workers who care for patients with infections and cancer and who are in need of antimicrobial therapy.
We welcome you all and wish you a fruitful conference and an enjoyable stay in Belgrade.
WELCOME ADDRESSIt is a great pleasure for us to welcome you to Belgrade!
Mijomir PelemisChair of 2nd SEEC
JUAH President
Andrea Novelli FESCI President
Teresita Mazzei ISC President
George L. Petrikkos MSC President
03.11
.201
1. T
hurs
day
Arriv
al an
d re
gistra
tion
09.0
0. to
19.
00W
elco
min
g re
cept
ion
20.0
0. H
otel
M.
04.11
.201
1. F
riday
Tim
eha
ll I
Tim
eha
ll II
08.0
0-10
.30
Chall
enge
s of a
ntim
icrob
ial th
erap
y tod
ay
Chair
s: M
ijom
ir Pele
mis,
Kra
ssim
ir Met
odiev
08.0
0-08
.45
Non-
Antib
iotic
s Ch
air: A
ndre
a No
velli
09.0
0-10
.30
Zoon
oses
in M
onte
negr
o Ch
airs:
Bog
dank
a And
ric, A
nna
Mas
seva
10.3
0-10
.50
brea
k10
.30-
10.5
0br
eak a
k10
.50-
12.2
0Cu
rrent
issu
es in
antib
iotic
stew
ards
hip
Chair
s: Ia
n M
Gou
ld, S
ilvan
o Es
posit
o10
.50-
12.2
0Co
mm
unity
aqui
red
pneu
mon
ia (C
AP)
Chair
s: G
aye
Uslue
r, Bru
no B
aršić
12
.20-
13.2
0lun
ch b
reak
12.2
0-13
.20
lunch
bre
ak13
.20-
15.2
0Re
cent
adva
nces
in th
e tre
atm
ent o
f inva
sive f
unga
l in
fect
ions
Chair
s: G
eorg
e Pe
trikko
s; An
drea
Nov
elli
13.2
0-15
.20
Zoon
oses
– em
ergi
ng p
ublic
hea
lth is
sues
Chair
s: G
eorg
ios P
appa
s, Ol
gica
Djur
kovic
-Djak
ovic
15.2
0-15
.40
brea
k15
.20-
15.4
0br
eak
15.4
0-17
.10
Upda
te o
n MR
SA
Chair
s: S
tefa
nia S
tefa
ni, Ia
n M
Gou
ld15
.40-
17.1
0Sh
ort c
omm
unica
tion
I
17.1
0-17
.30
brea
k17
.30-
18.1
5sa
tellit
e sy
mpo
sium
Poste
r will
be d
isplay
from
09.
00 to
18.
00 in
the
sepa
rate
hall
. Diss
cusio
n ab
out p
oste
rs w
ith a
utho
rs w
ill be
dur
ing lu
nch
brea
k.
scien
tific s
ympo
sium
shor
t com
mun
icatio
n
sate
lite sy
mpo
sium
spec
ial e
vent
s
1,2,3
• Nizak stepen rezistencije4
4,5,6,7,8
PharmaSwiss d.o.o. | Vojvode Stepe 18 | 11000 Beograd | Srbijatel. +381 (11) 3093-900 | fax. +381 (11) 3093-955
Reference: 1. 2. 3. Gilbert 4. Katherine F. Croom and Karen L. Goa, Levo-
5. File TM Jr,
-other. 1997;41(9):1965-1972. 6.
7.clinical enigma. Urology. 2005;66:2-8. 8.
PPFLEV-RS-11-7-1333
Samo za StruČnu javnoSt
Broj dozvole: 3245/2010/12 od 04.06.2010.
Levomax® rastvor za infuziju, 10 x 500mg/100ml:Broj dozvole: 3342/2010/12 od 09.06.2010.
05.11
.201
1. S
atur
day
Tim
eha
ll I
Tim
eha
ll II
08.2
0-10
.20
Colla
tera
l effe
cts o
f ant
iinfe
ctive
s- fr
om th
eory
to
prac
tice
Chair
s: M
ihai N
echif
or, M
ilan
Cizm
an08
.20-
10.2
0An
tivira
ls ar
e not
enou
gh –
pand
emic
influ
enza
co
ntro
vers
iesCh
airs:
Bru
no B
aršić
, Dali
bor V
ukeli
ć10
.20-
10.4
0br
eak
10.2
0-10
.40
brea
k10
.40-
12.4
0Ho
w to
cont
rol th
e res
istan
ce in
Gra
m-n
egat
ives
Chair
s: B
ojana
Beo
vic, G
eorg
e Ky
uchu
kov
10.4
0-12
.40
Infe
ctio
ns in
gyn
ecol
ogy a
nd o
bste
trics
Chair
s: U
do H
oym
e, C
hern
ev To
dor
12.4
0-13
.40
lunch
bre
ak12
.40-
13.4
0lun
ch b
reak
13.4
0-15
.40
Infe
ctio
us d
iseas
es in
mar
gina
lized
pop
ulat
ion:
ho
mele
ss, d
isplac
ed, R
omas
, who
nex
t Ch
airs:
Vlad
imir K
rcm
ery,
Mijo
mir P
elem
is13
.40-
15.4
0Im
porte
d tro
pica
l infe
ctio
ns
Chair
s: M
ilora
d Pa
vlovic
, Bog
dan
Petru
nov
15.4
0-16
.00
brea
k15
.40-
16.0
0br
eak
16.0
0-17
.30
Beta
-lact
am re
sista
nce p
robl
ems i
n So
uth
Euro
pe:
how
to d
eal w
ith?
Chair
s: Te
resit
a M
azze
i, Geo
rgios
L Pe
trikko
s16
.00-
17.3
0Sh
ort c
omm
unica
tion
II
17.3
0-17
.40
brea
k17
.40-
19.0
0Di
scus
sion
abou
t the
2nd
SEEC
and
3rd
SEEC
Poste
r will
be d
isplay
from
09.
00 to
18.
00 in
the
sepa
rate
hall
. Diss
cusio
n ab
out p
oste
rs w
ith a
utho
rs w
ill be
dur
ing lu
nch
brea
k.
scien
tific s
ympo
sium
shor
t com
mun
icatio
n
sate
lite sy
mpo
sium
spec
ial e
vent
s
06.11
.201
1. S
unda
y
Tim
eha
ll I
Tim
eha
ll II
08.0
0-10
.00
Urin
ary t
ract
infe
ctio
n an
d pr
osta
titis
Chair
s: K
urt N
aber
, Ank
a St
anojc
ic09
.00-
10.3
0No
vel th
erap
eutic
s in
the t
reat
men
t of h
uman
solid
tu
mor
s Ch
airs:
Enr
ico M
ini, Z
orica
Tom
asev
ic10
.00-
10.2
0br
eak
10.3
0-10
.50
brea
k10
.20-
11.5
0Sh
ort c
omm
unica
tion
III10
.50-
11.5
0Mu
ltidru
g re
sista
nce i
n ca
ncer
Chair
: Enr
ico M
iniLe
cture
incl.
disc
ussio
n ab
out 4
5 m
in11
.50-
12.1
0br
eak
12.1
0-13
.10
JUAH
cong
ress
Clos
ing ce
rem
ony
scien
tific s
ympo
sium
shor
t com
mun
icatio
n
sate
lite sy
mpo
sium
spec
ial e
vent
s
04.11.2011. Friday
Time hall I
08.00-10.30 Challenges of antimicrobial therapy todayChairs: Mijomir Pelemis, Krassimir Metodiev
1. Pharmacokinetic/pharmacodynamic considerations for some antibiotics: clinical implications - Milica Prostran/Serbia
2. Challenges of antimicrobial resistance and development of new antimicrobial – Mijomir Pelemis/Serbia
3. Challenges of antimicrobial therapy in nosocomial UTI and urosepsis – Kurt Naber/ Germany
4. Risk infections for bioterroristic threats - Krassimir Metodiev/ Bulgaria5. Nosocomial infections in neurosurgical clinics - George Kyuchukov/
Bulgaria10.30-10.50 break10.50-12.20 Current Issues in Antibiotic Stewardship
Chairs: Ian M Gould, Silvano Esposito1. The antibiotic paradox - Ian M Gould/UK2. Treatment of CVC infections - Silvano Esposito/Italy3. MRSA in severe infections today - Stefania Stefani/Italy
12.20-13.20 lunch break13.20-15.20 Recent advances in the treatment of invasive fungal infections
Chairs: George Petrikkos; Andrea Novelli1. The changing epidemiology of invasive fungal infections - Miranda Drogari-
Apiranthitou/Greece2. New azoles : advantages and disadvantages - Anastasia Antoniadou/
Greece3. Echinocandins: an update - George Samonis/Greece4. Amphotericin B: does it still have a role? - Georgios Petrikkos/Greece
15.20-15.40 break
15.40-17.10 Update on MRSA Chairs: Stefania Stefani, Ian M Gould
1. Treatment of bone and joint infection - Silvano Esposito/Italy2. Is vancomycin doomed? – Ian M Gould/UK3. New resistance mechanisms in staphylococci - Stefania Stefani/Italy
17.10-17.30 break
17.30-18.15 Pharma Swiss
04.11.2011. Friday
Time hall II
08.00-08.45 Non-AntibioticsChair: Andrea Novelli
1. Break troughs in the non-antibiotic research and the new possibilities of reversing resistance in MDR and XMDR – Jette E Kristiansen/Denmark
09.00-10.30 Zoonoses in MontenegroChairs: Bogdanka Andric, Anna Masseva
1. Transmissive zoonoses in Montenegro - Bogdanka Andric/Montenegro2. Neurocysticercosis – Brankica Dupanovic/Montenegro3. Antibiotic susceptibility of Salmonella species:a comparison of two year with
5 year survey – Gordana Mijovic/Montenegro10.30-10.50 Break10.50-12.20 Community aquired pneumonia (CAP)
Chairs: Gaye Usluer, Bruno Baršić1. Etiology and resistance problems in CAP - Oguz Resat Sipahi/Turkey2. Treatment options of CAP - Hakan Erdem/Turkey3. Immunomodulatory activity of antibiotics matters? – Bruno Barsic/Croatia
12.20-13.20 lunch break
13.20-15.20 Zoonoses – emerging public health issuesChairs: Georgios Pappas, Olgica Djurkovic-Djakovic
1. Epidemiological and clinical aspects of trichinellosis in Serbia: a 10- year experience – Milos Korac/Serbia
2. Toxoplasmosis in Serbia in the regional context - Olgica Djurkovic-Djakovic/Serbia
3. Brucellosis in the Balkans: how it evolves – Georgios Papas/Greece4. Vector-borne zoonoses - Serafim Kastanakis/Greece
15.20-15.40 break
15.40-16.25 Short communication I
scientific symposium short communication satelite symposium special events
05.11.2011. Saturday
Time hall I
08.20-10.20 Collateral effects of antiinfectives- from theory to practiceChairs: Mihai Nechifor, Milan Cizman
1. Problems in monitoring the collateral effects of antibacterial drugs - Mihai Nechifor/Romania
2. Insulin resistance a challenging effect of highly active antiretroviral therapy – Iona Diana Olaru/Romania
3. Economic impact of intervention in antimicrobial use in Slovenia - Milan Cizman/Slovenia
4. Monitoring non-hematological adverse effects related to administration of interferon in patients with chronic HCV infection – Ioana Diana Olaru /Romania
10.20-10.40 break10.40-12.40 How to control the resistance in Gram-negatives
Chairs: Bojana Beovic, George Kyuchukov1. Epidemiology of MDRO: how big is the problem? – Biljana Carevic/Serbia2. The role of antibiotic restrictions to control ESBL-producing bacteria –
Bojana Beovic/Slovenia3. How to choose appropriate carbapenem? – Bruno Barsic/Croatia4. Prevention of transmission of ESBL positive bacteria Tatjana Lejko-Zupanc/Slovenia
12.40-13.40 lunch break13.40-15.40 Infectious diseases in marginalized population: homeless, displaced, Romas,
who next Chairs: Vladimir Krcmery, Mijomir Pelemis
1. Infectious diseases in shelters for homeless – Jaroslava Sokolova/Slovakia 2. Infectious diseases in slums/owercrowded urban population in Kenya –
Lubomira Timona Alumbasi/Kenya3. Infectious diseases in Roma villages - Vladimir Krcmery/Slovakia4. Infectious diseases in AIDS orphanages/children – Jose Suvada/Uganda
15.40-16.00 break
16.00-17.30 Beta-lactam resistance problems in South Europe: How to deal with?Chairs: Teresita Mazzei, Georgios L Petrikkos
1. Beta-lactam resistance evolution in south Europe: where we are? – Stefania Stefani/Italy
2. Beta-lactam pharmacokinetics and PK-PD evaluation in different settings: Are we still always therapeutically successful? - Andrea Novelli/Italy
3. Should we modify our treatment approach both in Hospital and Community acquired infections? - George L Daikos/Greece
17.30-17.40 break
17.40-19.00 Discussion about the 2nd SEEC and 3rd SEEC
05.11.2011. Saturday
Time hall II
08.20-10.20 Antivirals are not enough – Pandemic influenza controversiesChairs: Bruno Baršić, Dalibor Vukelić
1. Clinical characteristics of adult patients with influenza in Slovenia – Blaz Pecavar/Slovenia
2. Is pandemic H1N1 neurotropic virus? – Marija Santini/Croatia3. ECMO in the treatment of ARDS caused by pandemic H1N1 – Marko
Kutlesa/Croatia4. H1N1 vaccine – facts and myths – Katarina Ilic/Serbia
10.20-10.40 break10.40-12.40 Infections in Gynecology and Obstetrics
Chairs: Udo Hoyme, Chernev Todor1. Laparoscopic diagnosis of chlamydial salpingitis - Udo Hoyme/Germany2. Antiphospholipid syndrome – algorithm for clinical behaviour and
management - Chernev Todor/Bulgaria3. Toxoplasmosis and CMV infection during pregnancy - Anastasia
Antoniadou/Greece4. Prevention of prematurity is possible by vaginal pH-selfscreening and early
treatment of threatening infection - Udo Hoyme/Germany12.40-13.40 lunch break13.40-15.40 Imported tropical infections
Chairs: Milorad Pavlovic, Bogdan Petrunov 1. Imported tropical infections – do we have the right answers – Milorad
Pavlovic/Serbia2. Severe and deadly malaria – 10 years experience – Lidija Lavadinovic/
Serbia3. Molecular characterization of the first autochthonous Dengue virus cases in
Croatia - Ivan-Christian Kurolt/Croatia4. The 2010 West Nine Virus and Outbreak in Greece - Sotirios Tsiodras/
Greece15.40-16.00 break
16.00-17.30 Short communication II
scientific symposium short communication satelite symposium special events
06.11.2011. Sunday
06.11.2011. Sunday
Time hall I
08.00-10.00 Urinary Tract Infection and ProstatitisChairs: Kurt Naber, Anka Stanojcic
1. Optimal management of uncomplicated UTI – Kurt Naber/Germany2. UTI in renal insufficiency – Anka Stanojcic/Serbia3. New treatment options against resistant uropathogens – Mete Cek/Turkey4. Diagnostics and treatment of chronic prostatitis – Goran Stimac/Croatia
10.00-10.20 break10.20-11.50 Short communication III 11.50-12.10 break12.10-13.10 JUAH congress
Time hall II
09.00-10.30 Novel Therapeutics in the Treatment of Human Solid Tumors Chairs: Enrico Mini, Zorica Tomasevic
1. Updates and perspectives in the medical treatment of renal cell carcinoma – Orlin Savov/Germany
2. Medical treatment of metastatic colorectal cancer: what’s new? – Enrico Mini/Italy
3. Advances in the medical treatment of breast cancer – Zorica Tomasevic/Serbia
10.30-10.50 break10.50-11.50 Multidrug resistance in cancer
Chair: Enrico Mini1. Overcoming multidrug resistance in cancer - József Molnár/ Hungary
Lecture incl. discussion about 45 min
scientific symposium short communication satelite symposium special events